ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 083,44
0,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TRxADE HEALTH Inc (MEDS)

  7. TRxADE HEALTH Inc (MEDS) Actualités

MEDS TRxADE HEALTH Inc

5,65
-0,40 (-6,61%)
25 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
TRxADE HEALTH Inc MEDS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,40 -6,61% 5,65 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,96 5,60 6,07 5,65 6,05
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/5/202423:00EDGAR2Form 8-K - Current report
17/5/202423:05EDGAR2Form PRE 14A - Other preliminary proxy statements
15/5/202422:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
23/4/202422:05GLOBETRxADE Health, Inc. Announces Receipt of Notice from Nasdaq..
06/3/202414:30EDGAR2Form 8-K - Current report
06/3/202414:05GLOBETRxADE Health, Inc. Announces Special Cash Dividend
26/2/202418:00EDGAR2Form SEC STAFF ACTION - SEC Staff Action: ORDER
16/2/202423:05EDGAR2Form 8-K - Current report
14/2/202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202415:07GLOBETrxade health, Inc files its 3Q 10Q
17/1/202415:05EDGAR2Form 8-K - Current report
16/1/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/1/202412:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:25EDGAR2Form 8-K - Current report
30/11/202300:13GLOBETRxADE Announces Receipt of Notification of Deficiency from..
28/11/202318:29EDGAR2Form 8-K - Current report
15/11/202319:51EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
17/10/202314:05GLOBETrxADE Health, Inc. affirms its commitment to the..
13/10/202319:25EDGAR2Form 8-K - Current report
12/10/202314:05GLOBESuperlatus Announces Distribution Partnership with North..
11/10/202322:05EDGAR2Form 8-K - Current report
04/10/202315:29EDGAR2Form 8-K - Current report
04/10/202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Acquires the..
25/9/202314:06EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/9/202323:28EDGAR2Form 8-K - Current report
08/9/202316:42EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07/9/202314:05GLOBESuperlatus Announces Planned Expansion into Pet Food Market
25/8/202312:15EDGAR2Form 8-K - Current report
24/8/202315:47EDGAR2Form 8-K - Current report
24/8/202314:05GLOBESuperlatus Innovates $151 Billion US Snacking Market with..
22/8/202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Agrees to..
18/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202316:25GLOBETRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14/8/202314:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/8/202312:20EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202315:05GLOBENewly merged Entity Superlatus, Inc with Trxade Health, Inc...
31/7/202315:40EDGAR2Form 8-K - Current report
31/7/202314:35GLOBETRxADE HEALTH, Inc. Announces Closing of Acquisition of..
14/7/202323:08EDGAR2Form 425 - Prospectuses and communications, business..
14/7/202323:07EDGAR2Form 8-K - Current report
14/7/202322:30GLOBETRxADE HEALTH, Inc. Amends Definitive Merger Agreement with..
10/7/202322:58EDGAR2Form 8-K - Current report
30/6/202315:25EDGAR2Form 425 - Prospectuses and communications, business..
30/6/202315:25EDGAR2Form 8-K - Current report
30/6/202314:05GLOBESuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive..
27/6/202314:00GLOBESuperlatus, Inc. Announces New Appointments to the..
23/6/202322:40GLOBETRxADE HEALTH, Inc. Issues Correction to Press Release..
23/6/202314:05GLOBESuperlatus, Inc. to Combine with TRxADE HEALTH, Inc., to..
21/6/202318:36GLOBETRxADE Health, Inc.’s Board of Directors Approves Reverse..

Dernières Valeurs Consultées

NASDAQ
MEDS
TRxADE HEALTH
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés